Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Imiglucerase), By Therapeutic Condition (MPS), By Route Of Administration (Oral), By End-use, By Region, And Segment Forecasts, 2025 - 2030

Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Imiglucerase), By Therapeutic Condition (MPS), By Route Of Administration (Oral), By End-use, By Region, And Segment Forecasts, 2025 - 2030


Glutamic Acid Market Growth & Trends

The global glutamic acid market size is expected to reach USD 20.46 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 8.6% from 2025 to 2030. Glutamic acid is widely used in dietary supplements owing to its ability to build protein building blocks and help to detoxify the body. The market is projected to witness significant growth over the forecast period owing to the increasing global demand for animal feed, coupled with the surging use of food additives and food enhancers in the industry.

The prices of glutamic acid vary as per grade. Strong demand for the product in the animal feed and food and beverage industries has increased the price of glutamic acid. Moreover, disturbance caused by the COVID-19 pandemic in the raw material supply chain is another factor behind the increasing prices of glutamic acid. In the year 2019, Evonik Industries AG has increased the prices of its glutamic acid products at the global level by 15% due to the escalating cost of required raw materials.

Manufacturers compete based on distribution channels and strive to expand their market reach to increase their market share and bolster the annual revenue. The companies also compete on the basis of profit margins due to their high dependence on the distribution network for sales, thus leading to high entry barriers for the market. Glutamic acid manufacturers focus on improving their products and enhancing their manufacturing capabilities to distinguish their products from the products of other manufacturers in the industry and enhance their market share.

In 2020, Asia Pacific accounted for the largest revenue share of over 50.0%. The market growth is credited to the increasing purchasing power of the consumers, the growing adoption of a healthy lifestyle, and the expansion of the end-use industries, such as animal feed, pharmaceutical, cosmetics and personal care, and food and beverage. The demand for animal feed in countries such as India and China is projected to grow due to the presence of an abundant livestock population.

Glutamic Acid Market Report Highlights
  • The food & beverages segment accounted for the largest share of 57.7% in the global glutamic acid market in 2024 due to the extensive use of glutamic acid as a flavor enhancer, particularly in the form of monosodium glutamate (MSG).
  • The pharmaceuticals segment is expected to grow at a CAGR of 9.1% from 2025 to 2030. This robust growth can be attributed to the increasing use of glutamic acid in drug formulations, which is an essential component in various medications.
  • Asia Pacific dominated the global glutamic acid market with a revenue share of 57.1% in 2024 due to the extensive use of glutamic acid in the food and beverage industry, particularly in countries like China and Japan, where MSG is a staple ingredient.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Therapeutic Condition
1.2.3. Route of Administration
1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Enzyme Replacement Therapy Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Enzyme Replacement Therapy Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Imiglucerase
4.4.1. Imiglucerase Market, 2018 - 2030 (USD Million)
4.5. Agalsidase Beta
4.5.1. Agalsidase Beta Market, 2018 - 2030 (USD Million)
4.5.2. Alglucosidase Alfa
4.5.3. Alglucosidase Alfa Market, 2018 - 2030 (USD Million)
4.6. Taliglucerase
4.6.1. Taliglucerase Market, 2018 - 2030 (USD Million)
4.7. Velaglucerase Alfa
4.7.1. Velaglucerase Alfa Market, 2018 - 2030 (USD Million)
4.8. Pegademase
4.8.1. Pegademase Market, 2018 - 2030 (USD Million)
4.9. Laronidase
4.9.1. Laronidase Market, 2018 - 2030 (USD Million)
4.10. Pancreatic Enzymes
4.10.1. Pancreatic Enzymes Market, 2018 - 2030 (USD Million)
4.11. Idursulfase
4.11.1. Idursulfase Market, 2018 - 2030 (USD Million)
4.12. Galsulfase
4.12.1. Galsulfase Market, 2018 - 2030 (USD Million)
4.13. Others
4.13.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Enzyme Replacement Therapy Market: Therapeutic Condition Business Analysis
5.1. Therapeutic Condition Market Share, 2024 & 2030
5.2. Therapeutic Condition Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Condition, 2018 to 2030 (USD Million)
5.4. Gaucher Disease
5.4.1. Gaucher Disease Market, 2018 - 2030 (USD Million)
5.5. MPS
5.5.1. MPS Market, 2018 - 2030 (USD Million)
5.6. SCID
5.6.1. SCID Market, 2018 - 2030 (USD Million)
5.7. Pompe Disease
5.7.1. Pompe Disease Market, 2018 - 2030 (USD Million)
5.8. Fabry Disease
5.8.1. Fabry Disease Market, 2018 - 2030 (USD Million)
5.9. Other
5.9.1. Other Market, 2018 - 2030 (USD Million)
Chapter 6. Enzyme Replacement Therapy Market: Route of Administration Business Analysis
6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Parenteral
6.4.1. Parenteral Market, 2018 - 2030 (USD Million)
6.5. Oral
6.5.1. Oral Market, 2018 - 2030 (USD Million)
Chapter 7. Enzyme Replacement Therapy Market: End Use Business Analysis
7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Infusion Centers
7.4.1. Infusion Centers Market, 2018 - 2030 (USD Million)
7.5. Hospitals
7.5.1. Hospitals Market, 2018 - 2030 (USD Million)
7.6. Other
7.6.1. Other Market, 2018 - 2030 (USD Million)
Chapter 8. Enzyme Replacement Therapy Market: Regional Estimates & Trend Analysis by Product, Therapeutic Condition, and End Use
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamic
8.4.2.2. Regulatory Framework
8.4.2.3. Competitive Insights
8.4.2.4. U.S. Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamic
8.4.3.2. Regulatory Framework
8.4.3.3. Competitive Insights
8.4.3.4. Canada Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamic
8.4.4.2. Regulatory Framework
8.4.4.3. Competitive Insights
8.4.4.4. Mexico Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamic
8.5.2.2. Regulatory Framework
8.5.2.3. Competitive Insights
8.5.2.4. UK Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamic
8.5.3.2. Regulatory Framework
8.5.3.3. Competitive Insights
8.5.3.4. Germany Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamic
8.5.4.2. Regulatory Framework
8.5.4.3. Competitive Insights
8.5.4.4. France Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamic
8.5.5.2. Regulatory Framework
8.5.5.3. Competitive Insights
8.5.5.4. Italy Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamic
8.5.6.2. Regulatory Framework
8.5.6.3. Competitive Insights
8.5.6.4. Spain Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key Country Dynamic
8.5.7.2. Regulatory Framework
8.5.7.3. Competitive Insights
8.5.7.4. Norway Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key Country Dynamic
8.5.8.2. Regulatory Framework
8.5.8.3. Competitive Insights
8.5.8.4. Denmark Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key Country Dynamic
8.5.9.2. Regulatory Framework
8.5.9.3. Competitive Insights
8.5.9.4. Sweden Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamic
8.6.2.2. Regulatory Framework
8.6.2.3. Competitive Insights
8.6.2.4. Japan Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamic
8.6.3.2. Regulatory Framework
8.6.3.3. Competitive Insights
8.6.3.4. China Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamic
8.6.4.2. Regulatory Framework
8.6.4.3. Competitive Insights
8.6.4.4. India Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamic
8.6.5.2. Regulatory Framework
8.6.5.3. Competitive Insights
8.6.5.4. South Korea Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key Country Dynamic
8.6.6.2. Regulatory Framework
8.6.6.3. Competitive Insights
8.6.6.4. Australia Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamic
8.6.7.2. Regulatory Framework
8.6.7.3. Competitive Insights
8.6.7.4. Thailand Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamic
8.7.2.2. Regulatory Framework
8.7.2.3. Competitive Insights
8.7.2.4. Brazil Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamic
8.7.3.2. Regulatory Framework
8.7.3.3. Competitive Insights
8.7.3.4. Argentina Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamic
8.8.2.2. Regulatory Framework
8.8.2.3. Competitive Insights
8.8.2.4. South Africa Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamic
8.8.3.2. Regulatory Framework
8.8.3.3. Competitive Insights
8.8.3.4. Saudi Arabia Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamic
8.8.4.2. Regulatory Framework
8.8.4.3. Competitive Insights
8.8.4.4. UAE Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamic
8.8.5.2. Regulatory Framework
8.8.5.3. Competitive Insights
8.8.5.4. Kuwait Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Carl Zeiss Meditec, Inc.
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Shire Plc;
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3 Sanofi S.A.
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.4. Biomarin Pharmaceutical Inc.
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. AbbVie
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Alexion Pharmaceuticals Inc.
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Allergan plc
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Horizon Pharma Public Limited Company
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Actelion (Janssen)
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Recordati Rare Diseases
9.5.10.1. Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
9.5.11. Protalix Biotherapeutics
9.5.11.1. Overview
9.5.11.2. Financial Performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic Initiatives
9.5.12. Amicus Therapeutics, Inc.
9.5.12.1. Overview
9.5.12.2. Financial Performance
9.5.12.3. Product Benchmarking
9.5.12.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings